134395-00-9Relevant articles and documents
PROCESS FOR THE CONTINUOUS MANUFACTURE OF STATINS
-
Page/Page column 25-31, (2021/06/04)
The present invention relates to process for the continuous manufacture of Statins or salts thereof. The present invention relates to process for the continuous manufacture of Atorvastatin or a salt thereof. The present invention relates to a continuous m
Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases
Mizoi, Kenta,Takahashi, Masato,Sakai, Sachiko,Ogihara, Takuo,Haba, Masami,Hosokawa, Masakiyo
, p. 261 - 269 (2019/06/27)
1. We investigated the structure-activity relationship of 31 kinds of synthesized atorvastatin esters, thioesters, amides and lactone, selected as prodrug models, for metabolic activation by microsomes and hydrolases. 2. The susceptibility to human carboxylesterase 1 (hCES1) was influenced not only by the size of the acyl group and alkoxy group but also by the degree of steric crowding around the alkoxy group. 3. The susceptibility to human carboxylesterase 2 (hCES2) increased with a decrease in electron density around the alkoxy group of the substrate. 4. Lactone was specifically hydrolyzed by paraoxonase 3 (PON3). 5. These findings should be useful in prodrug design for controlling metabolic activation.
Preparation method of crystal form I atorvastatin calcium
-
Paragraph 0043; 0052; 0058; 0064; 0069, (2020/02/29)
The invention discloses a preparation method of crystal form I atorvastatin calcium. The method includes the steps of: preparation of atorvastatin ester; preparation of an atorvastatin salt; preparation of atorvastatin calcium; refining an atorvastatin ca